A Phase 2 Randomized, Double-blind, Placebo-controlled Trial of Ambroxol as a Disease-modifying Treatment for Parkinson's Disease Dementia

被引：0
|
作者：
Pasternak, S.
Silveira, C.
Coleman, K.
Garcia, R.
Wells, J.
Borrie, M.
MacDonald, P.
Bartha, R.
Jenkins, M.
Morrow, S.
Mendonca, D.
Zou, G.
Finger, E.
Rupar, T.
Tirona, R.
Jog, M.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
106
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [41] A Double-Blind, Placebo-Controlled Study to Assess the Mitochondria-Targeted Antioxidant MitoQ as a Disease-Modifying Therapy in Parkinson's Disease
    Snow, Barry J.
    Rolfe, Fiona L.
    Lockhart, Michelle M.
    Frampton, Christopher M.
    O'Sullivan, John D.
    Fung, Victor
    Smith, Robin A. J.
    Murphy, Michael P.
    Taylor, Kenneth M.
    MOVEMENT DISORDERS, 2010, 25 (11) : 1670 - 1674
  • [42] Modafinil for the treatment of daytime sleepiness in Parkinson's disease:: A double-blind, randomized, crossover, placebo-controlled polygraphic trial
    Högl, B
    Saletu, M
    Brandauer, E
    Glatzl, S
    Frauscher, B
    Seppi, K
    Ulmer, H
    Wenning, G
    Poewe, W
    SLEEP, 2002, 25 (08): : 905 - 909
  • [43] MIRABEGRON FOR TREATMENT OF OVERACTIVE BLADDER SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE: A DOUBLE-BLIND, RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Cho, Sung Yong
    Jeong, Jin
    Kim, Janghwan
    Lee, Seong Ho
    Lee, Sangchul
    Choo, Min Soo
    Oh, Seung-June
    JOURNAL OF UROLOGY, 2020, 203 : E1023 - E1023
  • [44] Transdermal rotigotine - Double-blind, placebo-controlled trial in Parkinson disease
    Jankovic, Joseph
    Watts, Ray L.
    Martin, Wayne
    Boroojerdi, Babak
    ARCHIVES OF NEUROLOGY, 2007, 64 (05) : 676 - 682
  • [45] PBT2 in Huntington Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
    ANNALS OF NEUROLOGY, 2014, 76 : S51 - S52
  • [46] Pilot study of H2 therapy in Parkinson's disease: A randomized double-blind placebo-controlled trial
    Yoritaka, Asako
    Takanashi, Masashi
    Hirayama, Masaaki
    Nakahara, Toshiki
    Ohta, Shigeo
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2013, 28 (06) : 836 - 839
  • [47] Velnacrine for the treatment of Alzheimer's disease: A double-blind, placebo-controlled trial
    Zemlan, FP
    Folks, DG
    Goldstein, BJ
    Gottlieb, G
    Holub, RF
    Linden, RD
    Margolin, RA
    Richter, RW
    Speakman, WF
    Strub, RL
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) : 1105 - 1116
  • [48] Randomized placebo-controlled trial of memantine for dementia in Parkinson's disease
    Marsh, L.
    Biglan, K.
    Williams, J. R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S82 - S82
  • [49] Randomized Placebo-controlled Trial of Memantine for Dementia in Parkinson's Disease
    Marsh, Laura
    Biglan, Kevin M.
    Williams, James R.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (03): : S78 - S79
  • [50] A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
    Turner, R. Scott
    Thomas, Ronald G.
    Craft, Suzanne
    van Dyck, Christopher H.
    Mintzer, Jacobo
    Reynolds, Brigid A.
    Brewer, James B.
    Rissman, Robert A.
    Raman, Rema
    Aisen, Paul S.
    NEUROLOGY, 2015, 85 (16) : 1383 - 1391
12345